NEXT Oncology
Gina Mangold has a BS in Biomedical Science from Texas A&M University and an MBA in Finance from Our Lady of the Lake University. Gina has extensive experience in research administration and currently serves as the Executive VP & COO at NEXT Oncology San Antonio. Prior to this, Gina held the positions of COO at START- South Texas Accelerated Research Therapeutics, CEO at START Shanghai, and Director of Research Administration at the Institute for Drug Development. Gina also served as Director of Research Administration at the Cancer Therapy and Research Center.
NEXT Oncology
NEXT Oncology, founded by Anthony W. Tolcher, M.D., FRCPC, is a Phase 1 center dedicated to providing options for advanced cancer patients and advancing cancer research. Dr. Tolcher’s passion for research and the community lays the foundation for an international brand committed to finding the next breakthrough. Dr. Anthony Tolcher is a medical oncologist and co-founder of NEXT. He is dedicated to the development of new anticancer agents for patients whose current cancer therapy is no longer working to benefit them and are looking for their next option that includes clinical trials of new agents and therapies. Dr. Tolcher is proud that at NEXT Oncology the team scours the world to bring the best new agents back to our patients and centers. This is not a job for Dr. Tolcher, it is his passion.